As US medical device maker Medtronic looks to gain a stronger footing against the market’s top competitor Johnson & Johnson, reports say Medtronic has offered concessions to EU authorities to secure approval for its buyout plans.
Medtronic is seeking to acquire Irish rival Covidien for $43 billion. According to reports, that takeover would place Medtronic at a nearly even level with Johnson & Johnson and lessen its tax burden.
The European Commission said this week that Medtronic has submitted concessions for the deal, but declined to say what those concessions are. The watchdog said it will rule on the merger by November 28.
Earlier reports said Covidien was willing to sell certain assets to close the deal.
Medtronic is looking to increase its competitive edge and has denied any claims that the merger is an inversion deal aimed at lowering its tax rates, though the merger would accomplish just that.
Full content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI